Who is sponsoring NCT04993807?

NCT04993807 is sponsored by Columbia University.

What drugs are being tested in NCT04993807?

Interventions in NCT04993807: Shared decision-making tool.

What condition does NCT04993807 study?

NCT04993807 studies Atrial Fibrillation, Patient Engagement.

Is NCT04993807 still recruiting?

NCT04993807 is currently completed. Last updated 18 February 2026.

Last reviewed 2026-02-18 · How we verify

NCT04993807

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Data-driven SDM to Reduce Symptom Burden in AF

Completed NA Last updated 18 February 2026

What this trial tests

NA trial testing Shared decision-making tool in Atrial Fibrillation in 75 participants. Completed in 20 August 2025.

Timeline

25 March 2024

Primary endpoint
20 June 2025

20 August 2025

Quick facts

Lead sponsor	Columbia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	75
Start date	25 March 2024
Primary completion	20 June 2025
Estimated completion	20 August 2025
Sites	2 locations across United States

Drugs / interventions tested

Shared decision-making tool

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →
Patient Engagement — all drugs for Patient Engagement →

Sponsor

Columbia University

Who can join

18 and older, any sex, with Atrial Fibrillation or Patient Engagement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a single-group feasibility study evaluating decision aid visualizations which display common post-ablation symptom patterns as a tool for shared decision-making. The specific aim of the clinical trial is to evaluate the feasibility of putting the visualizations into clinical practice (n=75). The hypothesis is that patients will report low decisional conflict and decision regret and high satisfaction with their decision about whether to undergo an ablation or not.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Evaluating a digital decision aid for atrial fibrillation rhythm control in a hybrid implementation-effectiveness trial.
Reading Turchioe M, Shamnath A, Slotwiner D, Zhao Y, et al · · 2026 · PMID 41792400 · DOI 10.1038/s41746-026-02405-y

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04993807 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 18 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04993807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing